miércoles, 7 de octubre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· November 2, 2025

Datavault AI ออกแถลงการณ์อย่างเป็นทางการเพื่อตอบโต้รายงานสั้นโจมตีจาก Wolfpack Research โดยยืนยันจุดแข็งของทรัพย์สินทางปัญญา ทีมผู้นำ และทิศทางเชิงกลยุทธ์ของบริษัท

View original at globenewswire.com
Datavault AI ออกแถลงการณ์อย่างเป็นทางการเพื่อตอบโต้รายงานสั้นโจมตีจาก Wolfpack Research โดยยืนยันจุดแข็งของทรัพย์สินทางปัญญา ทีมผู้นำ และทิศทางเชิงกลยุทธ์ของบริษัท ฟิลาเดลเฟีย, Nov…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The Wolfpack report contains false, misleading, and defamatory statements designed to manipulate DVLT stock price for short sellers' financial gain

    80% confidence
  • Those who publish and promote 'distorted short reports' should be defendants in court, and that is what the company intends to do with Wolfpack Research

    80% confidence
  • The company intends to pursue legal action to hold Wolfpack Research accountable and protect shareholder rights

    80% confidence
  • This case will detail the specific false statements clearly enough to serve as a roadmap for federal law enforcement to prosecute the authors and supporters of Wolfpack Research's report

    80% confidence
  • Such deceptive and misleading actions create market confusion, destroy confidence, and damage shareholders. Mr. Bradley is fully committed to protecting his shareholders' interests

    80% confidence
  • Wolfpack Research has a short position in DVLT stock

    80% confidence
  • It is clear these individuals are seeking financial gain from disseminating false information

    80% confidence
  • Our strategy is grounded in intellectual property and real execution, not speculation

    80% confidence
  • Wolfpack Research published a malicious, self-serving short report attacking the company

    80% confidence
  • The technologies we have developed have been deployed to create value across multiple industries, from digital identity verification and healthcare to voice data processing and real-world asset tokenization on blockchain

    80% confidence
Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,986
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,986 hechos verificados con la fuente5,362 documentos fuente archivados
Consulta estos datos → isubstrate.com
Datavault AI ออกแถลงการณ์อย่างเป็นทางการเพื่อตอบโต้รายงานสั้นโจมตีจาก Wolfpack Research โดยยืนยันจุดแข็งของทรัพย์สินทางปัญญา ทีมผู้นำ และทิศทางเชิงกลยุทธ์ของบริษัท — Source | Via News | es.VIA.NEWS